PhD Ana Mitrović

PhD Ana Mitrović
no.: 36440 source: ARIS

researcher – active in research organisation
  ana.mitrovicat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
350.17
A''
24.57
A'
169.75
A1/2
192.8
CI10
673
CImax
97
h10
14
A1
1.19
A3
0
Data for the last 5 years (citations for the last 10 years) on December 8, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 32  784  630  19.69 
Scopus 33  827  666  20.18 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2013 
Doctoral degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Pharmacy 2017 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (50%, RD:50%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene)  5/1/2017  Assistant  Researcher  Teaching Assistant with Doctorate 
Full time employment (70%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  6/26/2023  Assistant  Researcher  Assistant professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. N1-0411  Two-photon-activated targeted cancer therapies   3/1/2025 - 2/29/2028  PhD Anja Pišlar   1,304 
2. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT   1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,328 
3. J4-4555  Exploring the biofilm phenotype and surfactome of Listeria monocytogenes to predict its persistence and pathogenicity potential using machine learning   10/1/2022 - 9/30/2025  PhD Jerica Sabotič   2,618 
4. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   10/1/2021 - 3/31/2025  PhD Ana Mitrović   2,885 
5. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,451 
6. J3-2516  Cystatin f as a mediator of immunosuppression in glioblastoma microenvironment   9/1/2020 - 8/31/2023  PhD Milica Perišić Nanut   2,949 
7. Z3-9273  Use of cathepsin B and X inhibitors for the improvement of antitumor therapy   7/1/2018 - 6/30/2020  PhD Ana Mitrović   145 
8. J4-8227  Preprečevanje rezistence tumorskih celic na antiproteazno terapijo z inhibitorji katepsina X. (Slovene)   5/1/2017 - 4/30/2020  PhD Janko Kos   5,177 
9. J4-6811  Vloga inhibitorjev cisteinskih proteaz v citotoksičnem delovanju naravnih celic ubijalk na tumorske celice (Slovene)   7/1/2014 - 6/30/2017  PhD Janko Kos   2,837 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Anja Pišlar   5,816 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,473 
3. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   5,995 
Confirmation required
Views history
Favourite